In a sign that pain management for patients dying of cancer is worsening, a new study by Dana-Farber Cancer Institute investigators has found a sharp decline in opioid access among these patients over a recent 10-year period, even as many more of them turned to hospital emergency rooms for pain treatment.
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.
A new study led by scientists from the International Agency for Research on Cancer shows that an estimated 741,000 new cases of cancer in 2020 were associated with alcohol consumption globally.Â
A new prognostic tool helps predict which men with advanced metastatic prostate cancer will respond favorably to a novel targeted therapy.Â
A cancer survivorship study is focusing on Kentucky cancer survivors with any type of cancer, and comparing the results within the state.Â
St. Jude Children’s Research Hospital scientists have created a registry, Molecular Analysis of Childhood MELanocytic Tumors (MACMEL), to better understand pediatric melanoma. Â
Findings from the health outcomes group at Fred Hutchinson Cancer Research Center show that more Medicaid patients with cancer died at home without hospice care during the COVID-19 pandemic.
A study led by researchers at NYU Langone Health and Perlmutter Cancer Center shows that Black men most likely to benefit from advanced prostate cancer therapies are 11% less likely to get them than non-Black men.Â
Researchers at City of Hope have identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published in Nature Cancer.
The ABAT enzyme helps medulloblastoma cells feed, according to a study led by USC Brain Tumor Center and Norris Comprehensive Cancer Center.
